Frontiers in Aging Neuroscience (Aug 2021)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features

  • William J. Griffiths,
  • Jonas Abdel-Khalik,
  • Sarah F. Moore,
  • Ruwani S. Wijeyekoon,
  • Peter J. Crick,
  • Eylan Yutuc,
  • Krista Farrell,
  • David P. Breen,
  • David P. Breen,
  • David P. Breen,
  • Caroline H. Williams-Gray,
  • Spyridon Theofilopoulos,
  • Ernest Arenas,
  • Miles Trupp,
  • Roger A. Barker,
  • Roger A. Barker,
  • Yuqin Wang

DOI
https://doi.org/10.3389/fnagi.2021.685594
Journal volume & issue
Vol. 13

Abstract

Read online

Disordered cholesterol metabolism is linked to neurodegeneration. In this study we investigated the profile of cholesterol metabolites found in the cerebrospinal fluid (CSF) of Parkinson’s disease (PD) patients. When adjustments were made for confounding variables of age and sex, 7α,(25R)26-dihydroxycholesterol and a second oxysterol 7α,x,y-trihydroxycholest-4-en-3-one (7α,x,y-triHCO), whose exact structure is unknown, were found to be significantly elevated in PD CSF. The likely location of the additional hydroxy groups on the second oxysterol are on the sterol side-chain. We found that CSF 7α-hydroxycholesterol levels correlated positively with depression in PD patients, while two presumptively identified cholestenoic acids correlated negatively with depression.

Keywords